Capricor Therapeutics
CAPR
#7991
Rank
A$0.43 B
Marketcap
A$9.56
Share price
-4.36%
Change (1 day)
-59.02%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -A$0.13 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are A$11.13 Million. In 2024 the company made an earning of -A$60.81 Million a decrease over its 2023 earnings that were of -A$33.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.13 Billion108.99%
2024 -A$60.81 Million81.57%
2023 -A$33.49 Million-23.2%
2022 -A$43.61 Million44.93%
2021 -A$30.09 Million46.61%
2020 -A$20.53 Million78.71%
2019 -A$11.49 Million-49.7%
2018 -A$22.83 Million-724.78%
2017 A$3.65 M-112.93%
2016 -A$28.26 Million46.27%
2015 -A$19.32 Million106.82%
2014 -A$9.35 Million-48.41%
2013 -A$18.11 Million977.23%
2012 -A$1.69 Million-77.11%
2011 -A$7.35 Million-22.35%
2010 -A$9.46 Million-20.17%
2009 -A$11.85 Million-41.17%
2008 -A$20.14 Million41.05%
2007 -A$14.28 Million1098.87%
2006 -A$1.2 Million4101.55%
2005 -A$0.03 Million-0.97%
2004 -A$0.03 Million17.87%
2003 -A$0.03 Million3.66%
2002 -A$0.03 Million-30.11%
2001 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cytokinetics
CYTK
-A$1.13 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$25.99 Million-78.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.67 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.87 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.39 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$14.26 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA